Skip to content
Go to InnovestGlobal.com
Our Mission
Our Culture
Press Releases
Financial Reports
Corporate Governance
Executive Leadership
Board of Directors
Investor Resources
Stock Information
Events & Presentations
RSS Feeds
Contact
Go to InnovestGlobal.com
OTC Markets: IVST
$0.07
-0.01315 (-16.44%)
July 28, 2021 7:55 PM
Our Mission
Our Culture
Press Releases
Financial Reports
Corporate Governance
Executive Leadership
Board of Directors
Investor Resources
Stock Information
Events & Presentations
RSS Feeds
Contact Us
Press Releases
Innovest Global Announces DTC Eligibility for Common Shares
January 4, 2021
Innovest Global Shareholder Update Highlights HIPAA Compliant Call Center
November 17, 2020
Innovest Global Launches New Platform for Fast-Growing Modular Industry
October 8, 2020
Innovest Global Secures Letter of Intent With Major Hotel Group for $54 Million in Revenue from New Product Line Launch
October 6, 2020
Innovest's Building Solutions Division Growing Rapidly Through New Acquisition and Expanded Products and Services
September 29, 2020
Innovest Global Awarded New Contracts From Recently Launched COVID-19 Safety Program for Safe and Effective Return to School and Workplaces
September 15, 2020
Innovest Global Completes Sale of StemVax Therapeutics to NovAccess Global
September 10, 2020
Innovest Global Appoints Daniel (Danny) Baker to Board of Directors
September 1, 2020
Innovest Global Appoints Damon Mintz as Chief Executive Officer
August 20, 2020
Innovest Global Enters into Agreement for the Sale of StemVax Therapeutics to XsunX, Inc.
August 10, 2020
Innovest Global Announces $6.0 Million Contract Renewal with Fortune 500 Healthcare Company
August 3, 2020
View Archived Press Releases
